2016
DOI: 10.1017/s0031182016000627
|View full text |Cite
|
Sign up to set email alerts
|

Development of a recombinant protein-based ELISA for diagnosis of larval cyathostomin infection

Abstract: accession numbers: JN596964 (Cy-gala-ash), JN596966 (Cy-gala-cat), JN596967 (Cy-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
18
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 15 publications
(21 citation statements)
references
References 54 publications
3
18
0
Order By: Relevance
“…An ELISA was developed based on recombinant Cy-GALA proteins, which allows the detection of the immune response to cyatostomin larvae. Cross-reactivity to other parasites was not observed and is unlikely, because of the diversity of orthologous GALA sequences of non-cyathostomin species (Mitchell et al, 2016). In the absence of experimental single species infections, cross-reactivity between cyathostomin species is hard to evaluate and diagnostic tests should therefore include a panel of different Cy-GALA proteins to detect most larval cyathostomin infections.…”
Section: Serological Methodsmentioning
confidence: 99%
“…An ELISA was developed based on recombinant Cy-GALA proteins, which allows the detection of the immune response to cyatostomin larvae. Cross-reactivity to other parasites was not observed and is unlikely, because of the diversity of orthologous GALA sequences of non-cyathostomin species (Mitchell et al, 2016). In the absence of experimental single species infections, cross-reactivity between cyathostomin species is hard to evaluate and diagnostic tests should therefore include a panel of different Cy-GALA proteins to detect most larval cyathostomin infections.…”
Section: Serological Methodsmentioning
confidence: 99%
“…For this reason, it is currently recommended that FEC-directed protocols be augmented with at least one treatment aimed to be effective against these parasitic species and stages – for example, moxidectin administration in the late autumn/winter in temperate areas in the northern hemisphere (Hertzberg and others 2014). An ELISA diagnostic test is being developed to detect infection with encysted cyathostomins (Mitchell and others 2016) and a real-time quantitative PCR test has been developed to detect Strongylus vulgaris infection (Nielsen and others 2012a). …”
Section: Sustainable Control Strategiesmentioning
confidence: 99%
“…As no new anthelmintic classes are under development for use in horses in the short to medium term, it is important that the efficacy of currently effective compounds is preserved. Recommendations for control now place a strong emphasis on reducing anthelmintic treatment frequency (Matthews, 2014;Tzelos and Matthews, 2016). Because cyathostomin infections exhibit a negative binomial distribution amongst hosts (Lester et al, 2013;Relf et al, 2013;Wood et al, 2013), substantial reductions in treatment levels can be achieved by targeting anthelmintics based on worm egg shedding levels.…”
Section: Introductionmentioning
confidence: 99%
“…Because cyathostomin infections exhibit a negative binomial distribution amongst hosts (Lester et al, 2013;Relf et al, 2013;Wood et al, 2013), substantial reductions in treatment levels can be achieved by targeting anthelmintics based on worm egg shedding levels. Faecal egg count (FEC)-directed treatments are thus recommended (Sangster, 2003;Kaplan and Nielsen, 2010;Nielsen et al, 2014;Tzelos and Matthews, 2016), with good uptake in some regions (Easton et al, 2016, Tzelos et al, 2019. A main disadvantage of FEC analysis is the lack of information on total intra-host burden; in terms of targeting larvae to avoid disease, FEC tests therefore do not provide the relevant information.…”
Section: Introductionmentioning
confidence: 99%